Carboxyl-Terminal Truncated HBx Regulates a Distinct MicroRNA Transcription Program in Hepatocellular Carcinoma Development
W.K. Yip(Chinese University of Hong Kong), Henry Lik‐Yuen Chan(Radiant Research (United States)), Jonathan Gabriel Sung(Chinese University of Hong Kong), Joseph J.�Y. Sung(Nanyang Technological University), Ka‐Fai To(Chinese University of Hong Kong), Yangchao Chen(Guangzhou University of Chinese Medicine), Alfred S.L. Cheng(Chinese University of Hong Kong), Jun Yu(Yueyang Second People's Hospital), Vincent Wai‐Sun Wong(Chinese University of Hong Kong), Daisy P. Tsang(Therapeutics Clinical Research), Nathalie Wong(Chinese University of Hong Kong), Ranxu Zhu(Chinese University of Hong Kong), Enders Kai‐On Ng(Chinese University of Hong Kong), Paul B.S. Lai(Chinese University of Hong Kong), Suki S. Lau(Chinese University of Hong Kong), Raymond Wai Ming Lung(Chinese University of Hong Kong)
Cited by 74
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
|Journal of Clinical Oncology|2014|2.8k
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.8k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
|The Lancet. Gastroenterology & hepatology|2016|2k